Sarissa Consulting’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,500
Closed -$508K 73
2022
Q2
$508K Buy
+15,500
New +$490K 0.72% 41

Other funds holding NTUS

Sarissa Consulting's NTUS Position: Q3 2022 in Review

Sarissa Consulting sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 15,500 shares — an estimated $508K sold.

Sarissa Consulting first reported a position in NTUS in Q2 2022 and held it in 1 quarter. The position peaked at $508K in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Sarissa Consulting reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Sarissa Consulting sold 15,500 Natus Medical Inc shares in Q3 2022, an estimated $508K.
  • Sarissa Consulting first reported a position in Natus Medical Inc in Q2 2022 and held it in 1 quarter.
  • Sarissa Consulting's Natus Medical Inc position peaked at $508K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Sarissa Consulting's 13F filing for Q3 2022, filed 14 Nov 2022.